The biggest F50 exit of 2024 was Rubrik (IPO in April 2024 at a $5.6 billion valuation). Additional exits included Wib and ...

Nebius is the likely AI megatrend winner with the AI investment cycle is still in its early stages. Click here to read an ...

That's a mistake that plagued digital health companies in the last cycle of IPOs, he said, adding that there are still startups considering IPOs in the next cycle that haven't reached profitability.

Wall Street is gearing up for another wave of blank check companies from seasoned and first-time sponsors, showing the ...

Smithfield Foods (NASDAQ:SFD) opened on Monday with a swing higher after the post-IPO quiet period on the stock expired on Monday to free up analysts to post ratings. The food processing stock landed ...

Anything else startups should know that might impact this next cycle of IPOs? While these companies that went public in the last cycle may not have fulfilled their promises, they set the stage for ...

And that's why you need to be extra wary of the IPO cycle. Let's go over this. We've seen the pattern over and over again. We get this deluge of new deals, at first, many of them explode higher, but ...

SYDNEY/SEOUL, Feb 5 (Reuters) - Shares of a small Japanese technology firm shot up nearly 60% on its first day of trade on Wednesday, while Seoul's largest initial public offering (IPO ...

“In the previous IPO cycle, there were effectively extended escrow periods for private equity exiting businesses there, which has given investors greater comforts there that the profit levels ...

Apollo Global Management’s plan for a multibillion-dollar buyout fund is one sign that private equity activity may revive this year as dealmaking gains momentum. At $25 billion, Apollo’s 11th ...

“It’s an emotional cycle right now,” said Nitin Bhasin ... are holding back the urgency in which they wanted to launch the IPO — they are happy to delay it by a month or two.” ...

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Recently. In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against the ...